COFCO Biotechnology Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 10,501.44 million compared to CNY 11,839.12 million a year ago. Revenue was CNY 10,609.26 million compared to CNY 12,026.43 million a year ago.

Net income was CNY 785.69 million compared to CNY 700.18 million a year ago. Basic earnings per share from continuing operations was CNY 0.4229 compared to CNY 0.3783 a year ago. Diluted earnings per share from continuing operations was CNY 0.4229 compared to CNY 0.3775 a year ago.